Felan Bronchialpastillen
Felan Bronchialpastillen is a medicine authorised by Swissmedic under authorisation number 67700. The authorisation holder is G-Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is E: Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products. First authorisation was granted on 14 November 2019 and the authorisation is valid without a time limit. ATC code R05FB02 places the medicine in the group Cough and cold preparations.
| Authorisation number | 67700 |
|---|---|
| Name | Felan Bronchialpastillen |
| Full name | Felan Bronchialpastillen |
| Authorisation holder | G-Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | E · General sale |
| ATC code | R05FB02 |
| First authorisation | 14 November 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Felan Bronchialpastillen | E | 14 November 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 40 | Tablette(n) | R05FB02 | 03.02.0. | E |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Felan Bronchialpastillen authorised in Switzerland?
Yes. Felan Bronchialpastillen is authorised by Swissmedic under authorisation number 67700, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Felan Bronchialpastillen have?
Felan Bronchialpastillen is in dispensing category E. Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products.
Who is the authorisation holder of Felan Bronchialpastillen?
The authorisation holder is G-Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.